Objective: To evaluate whether the dermal exposure to N,N-dimethylformamide (DMF) exerts significant effects and to determine the unit increment of dermal exposure on the total body burden of two biomarkers in urine: metabolism-required N-methylformamide (U-NMF) and non-metabolized DMF (U-DMF) in actual occupational environments. Methods: Exposure via respiratory and dermal routes was assessed on an individual basis for 75 workers from four DMF-related factories directly exposed to DMF. Respiratory exposure was determined by breathing-zone sampling for a full-work shift, and dermal exposure was assessed on the palms and forearms of both hands by an adhesive tape-patch method. U-NMF and U-DMF collected immediately postshift were measured. Results: The average concentrations of airborne DMF, DMF on hands and on forearms, U-NMF, and U-DMF (GM) were 1.51 ppm, 0.04 mg/cm 2 , 0.03 mg/cm 2 , 0.47 mg/l, and 0.38 mg/l, respectively. In multiple linear regression tests, only airborne DMF and DMF on hands remained significantly (Po0.001) associated with U-NMF and U-DMF. Based on model estimates, the unit increment of hands' exposure (mg/cm 2 ) could contribute to 0.53 and 0.46 mg/l of the increment of U-NMF and U-DMF, respectively, given a daily occupational airborne exposure to DMF at about 1.5 ppm. Conclusions: Dermal exposure provides a substantial contribution to the total body burden of DMF. A control remedy such as the enforcement of wearing impermeable gloves by workers occupationally exposed to DMF should be implemented with the highest priority.
Introduction N,N-dimethylformamide (DMF) has been widely used in industries (synthetic leather, polyurethane resin, Orlon s , and polyacrylic fibers, etc.) and termed the universal organic solvent because of its extensive miscibility with water and most common organic solvents (toluene, ethyl acetate, ketone, etc.) . However, overexposure to DMF has been associated with hepatoxicity, alcohol intolerance (Calvert et al., 1990) , male reproductive cancers, and possible embryotoxicity and teratogenicity in humans and animals (Hansen and Meyer, 1990 ). The current permissible exposure limit for DMF in the workplace is 10 ppm in US and in Taiwan.
The exposure to DMF via the respiratory tract in occupational environments has been studied intensively in epidemiological research. Recent studies, however, indicate that exposure to DMF via a dermal route has become increasingly important. An experiment conducted with human volunteers showed that percutaneous absorption of DMF vapor accounted for 13-36% of the dose absorbed through the lungs (Mraz and Nohova, 1992) . Another human exposure study (Nomiyama et al., 2001) found that the proportions of DMF vapor absorbed through the skin were higher than through inhalation (59.64 vs. 40.36%). These two studies were carried out in well-controlled exposure conditions and the vapor exposure, liquid contact, and respiratory exposure were implemented separately. However, in an actual occupational environment, the workers might be dermally exposed to DMF by its vapor and DMF liquid simultaneously. A study conducted in an occupational environment to assess the contribution of dermal exposure to DMF is still lacking.
Biological monitoring is considered to be more precise and accurate than environmental monitoring when determining the total body burden of chemical exposure for individual workers (WHO, 1995) . The urinary levels of N-methylformamide (U-NMF), one of the biotransformation products of DMF in humans, was recommended as the biomarker of the body burden indicator of DMF exposure by both the American Conference of Governmental Industrial Hygienists (ACGIH) (ACGIH, 1999) in the USA and the Deutsche Forschungsgemeinschaft (DFG) in Germany (Deutsche Forschungsgemeinschaft, 2000) . The current biological exposure index of U-NMF for DMF exposure in the workplace is 15 mg/l for both institutes.
DMF is hydrolyzed into N-hydroxymethyl-N-methylformamide (HMMF) by cytochrome P4502E1 in humans (Mra´z et al., 1993) , and is then metabolized into a great number of metabolites, including NMF (Kestell et al., 1986; Gescher 1993; Kafferlein and Angerer, 1999) . HMMF, the predominant metabolite (accounting for 50-80% of the absorbed dose), is difficult to identify owing to its easy thermodegradation into NMF during gas chromatograph analysis. Thus, the U-NMF levels represent the sum of U-HMMF and U-NMF (Scailteur et al., 1984; Brindley et al., 1993) . U-NMF, therefore, represents the metabolismrequired biomarker, contrasting to intact form of DMF in urine (U-DMF), representing the non-metabolized biomarker. The aims of this study were to evaluate whether the dermal exposure to DMF exerts significant effects and to determine the unit increment of dermal exposure on the total body burden of two biomarkers in urine: metabolismrequired U-NMF and non-metabolized DMF (U-DMF) in actual occupational environments.
Methods

Subject Recruitment
In all, 75 workers directly exposed to DMF in a copperlaminated circuit board factory (A), a synthetic acrylic fiber factory (B), and two synthetic leather factories (C and D) in Taiwan were recruited for this study. A questionnaire asking about age, work history, medical history, alcohol drinking and smoking habits, and other potential sources of exposure to DMF was administered during person-to-person interviews. None of the participants reported liver or kidney disorders in the person-to-person interviews, and yearly health examination reports documented no diagnosed liver or kidney disorders. According to interview-administered questionnaires, none of the participants was exposed to possible DMF-containing household products such as printing ink, shoe-polishing gel, or paint stripper. Throughout the study period, none of the participants wore a respirator, and none worked or went back to the working area during their offwork hours. Each participant read and signed the consent forms approved by our institution's Institutional Review Board before the study began.
Environmental Monitoring on Airborne and Dermal Exposure to DMF
Breathing-zone monitoring of DMF exposure covering the full-work shift was implemented on an individual basis for the 75 workers. The exposure-monitoring method applied in a previous study was adopted with minor modification (Chang et al., 2003) . In brief, a passive badge containing activated charcoal (3 M 3500; 3 M Co., St. Paul, MN, USA) worn on the right collar of each participant throughout the working period was used as a sampling adsorbent. The charcoal was extracted with 1.5 ml extraction solvent composed of carbon disulfide (HPLC grade; Tedia, Fairfield, OH, USA) and n-pentanol (American Chemical Society certified; Fisher Scientific, Pittsburgh, PA, USA) with the ratio of 20%:80% (v:v) for 30 min before instrumental analysis. A total of 10% of the samples from the same batch of charcoal badges were used for blank checkup (field blanks and sampling medium blanks), and were analyzed together with other samples collected in the field. No observable peak was found in chromatograms for blank samples. A gas chromatograph (GC) equipped with a thermionic-sensitive detector (Varian 3600 CX GC/TSD; GenTech Scientific, Inc., Arcade, NY, USA) coupled to an auto-sampler (Varian 8200 CX; GenTech) was used in this study. A DB-WAX (WCOT coating with 1.0 mm film thickness of polyethylene glycol; J & W Scientific, Folsom, CA, USA) open tubular column 0.53 mm ID and 30 m in length was used as the analytical column. The injector and detector temperatures of the GC were set at 2101C and 2301C, respectively. The twostage ramp temperature program of the column was as follows: the column was heated at a temperature of 551C for 2 min in the initial stage. It was then heated at a program rate of 51C/min to 801C for 3 min, and then further heated at a program rate of 201C/min for 2 min to the final column temperature of 1301C. The flow rates of air and hydrogen were 175 and 4 ml/min, respectively. Nitrogen was used as a carrier and make-up gas with flow rates of 10 and 25 ml/min, respectively. All the sample analyses were completed within 2 weeks of the sample collection.
A quality assurance protocol for the sampling and analysis of airborne DMF (A-DMF) was implemented before the field study. The correlation coefficients (r) of the five-point calibration curves for DMF (HPLC grade; Tedia) were 40.995. The result of recovery efficiency tests performed by spiking liquid DMF at the amounts equivalent to 0.5 Â , 1 Â , and 2 Â TLV levels for the recommended sampling volumes into the charcoal was 93.874.3% (mean7standard deviation (SD)). All the A-DMF concentrations in the field studies were adjusted for their corresponding recoveries. The detection limit was 0.53 mg/ml.
Personal monitoring for dermal exposure to DMF was conducted for each participant. As the gloves cause substantial inconvenience to the manufacturing operations, the workers wear cotton gloves only in moving heavy instruments or products. Throughout the study period, the study subjects wore no gloves. After the factory walkthrough and consultation with the participating workers, the investigators decided that the possible skin exposure sites for workers were hands and forearms because other body sites were either covered by clothing or unlikely to be exposed to any material at work. A 10 cm 2 (3 M Series 845; 2.5 cm Â 4 cm) patch of adhesive tape was applied right before the end of the work shift to assess the dermal exposure during the work day (Rougier et al., 1999) . For hands, the tape patch was applied on the palm and dorsal side of both hands. For forearms, it was applied on the ventral part for both sides. To avoid the possibility of contamination, we used forceps to apply all tape patches. We also applied identical tape patches on the paravertebral area of the seventh cervical spine process as the control because this area was fully covered by clothes as well as on the opposite site against the contaminant source. Immediately after the patch was removed, it was transferred to a 10-ml vial containing 5 ml desorption solvent. The vial was sealed with a Teflon s cap immediately and stored in a freezer until analysis. Before instrumental analysis, the vial was further treated by ultrasonic vibration for 2 min.
The tape-patch recovery rates were determined by using the skin of the nude mice (BALB/cAnN-nu, 7 weeks old; from the Animal Facility Center. National Science Council, Taiwan). A volume of 2 ml of pure DMF was spiked onto the abdomen and back parts of three nude mice. After standing still for 2 min, the same tape-patch procedure as for the field samples was used. The recovery rates were around 35.0715.7% based on three consecutive experiments. The dermal exposure measurements were presented after adjusting the recovery rates. All measurements performed on the paravertebral area of seventh cervical spine process were below the detection limit (0.03 mg/ml), indicating neither background level nor contamination in the assessment of dermal exposure during the field study.
Biological Monitoring Strategies and Urine analysis
Urine specimens were collected from each worker immediately postshift in parallel with environmental sampling. Spot urine was collected in precleaned polyethylene plastic cups. The creatinine concentrations for each urine sample were measured and recorded. Right after collection, aliquots of each urine sample were kept at 41C and analyzed within 24 h for creatinine concentration using the Jaffe reaction in an autoanalyzer (Henry et al., 1974) . Samples with a creatinine concentration 43.4 or o0.3 g/l were excluded from data analysis due to possible renal function disorder in the test subject (Rosenberg et al., 1995) . Before GC analysis for U-NMF and U-DMF, the urine samples were stored at -701C. All samples were analyzed within a month from the time of collection. Urine preparation and analysis methods were as previously published (Kuo et al., 2000; Chang et al., 2003) . In brief, promptly thawed urine samples at 371C were centrifuged at 5000 rpm for 20 min. The supernatant (0.5 ml) was added to 0.5 ml methanol (HPLC grade; Tedia), kept in a 41C ice bath for 15-20 min, and then was further centrifuged at 5000 rpm for 10 min before instrumental analysis.
The same GC/TSD and analytical column used in the analyses of airborne exposure to DMF was used in urine analysis, but a different temperature program was applied. The column was initially heated to 801C for 2min, subsequently heated with a program rate of 101C/min for 3 min to 1101C, and then with another program rate of 201C/ min for 5 min to a final column temperature of 2101C.
We used a separate quality assurance protocol for the analysis of U-NMF and U-DMF. All the measurements were implemented using triplicate analyses. The correlation coefficients (r) of the five-point calibration curves for NMF (GC grade; Fluka, Sigma-Aldrich, Buchs SG, Switzerland) and DMF (HPLC grade; Tedia) in blank urine were 40.995 with relative standard deviations of o10%. The recovery tests were performed by spiking NMF and DMF into blank urine at concentrations of 7.5, 15, and 30 mg/ml and all recoveries were above and 75.0% with standard deviations less than 2.0%. All urine concentrations in the study were reported with the adjustment for their corresponding recoveries. The limit of detection was 0.33 mg/injection.
Data Analysis
The Shapiro-Wilks W-test was performed to assess the normality of the concentration distributions of airborne, dermal, and biological samples. The concentration distributions of A-DMF, dermal DMF, U-NMF, and U-DMF were all shown to be log-normally distributed. Thus, the geometric mean (geometric standard deviation) (GM (GSD)) was used to present the central tendency and the degree of dispersion of the measurements. One-way analysis of variation (ANO-VA) and the F-test were used for determining whether factory-to-factory variation was significant for A-DMF, DMF on skin, U-NMF, and U-DMF. The Spjotvoll/Stoline test (Tukey HSD for unequal N-test) was applied in post hoc comparisons. Simple and multiple linear regression tests were used to determine the dermal exposure contribution in addition to respiratory exposure contribution to U-NMF and U-DMF. ND (not detectable) was designated as onehalf of LOD (limit of detection) (Hornumg and Reed, 1990) . Statistica Software (release 5.0; StatSoft, Inc., Tulsa, OK, USA) was used for all statistical analyses. Statistical significance was set at Po0.05.
Results
The 75 workers participating in this study were male, were an average of 39.5 years old, and had worked in the factories for an average of 11.1 years ( Table 1) . Most of them smoked (61.3%) and less than a half of them drank alcohol (44.0%). The workers in factory B were, however, significantly older and had worked longer than those in factories A and D.
Throughout the study, 75 samples were successfully collected and analyzed for air monitoring and for urinary biological monitoring. For dermal exposure assessment, there were 73 samples on hands and on forearms. The average A-DMF concentrations (GM [GSD]) collected in the working environment were 1.51 (4.81) ppm (Table 2) . A-DMF concentrations in factories C and D were significantly greater than those in A and B. The average concentrations of dermal exposure on hands and on forearms were 0.01 (4.61) and 0.001 (5.98) mg/cm 2 , respectively (Table 3 ). There were some significant differences in dermal exposure among factories, for example, both DMF concentrations on hands and forearms in plant C were significantly greater than those in factories A and B, and those in factory D were significantly greater than those in the other three factories. In general, dermal exposures on hands were greater than those on forearms. For biological monitoring, the average concentrations of U-NMF and U-DMF were 0.47 (12.68) and 0.38 (9.21) mg/l, respectively (Table 4 ). Significant differences (Po0.01) both in U-NMF and U-DMF among factories were found (F ¼ 103.8 and 40.7, respectively) by one-way *Significant differences (Po0.01) both in U-NMF and U-DMF among factories were found (F ¼ 103.8 and 40.7, respectively) by one-way ANOVA tests. For both U-NMF and U-DMF, the factory-to-factory differences were found to be between A, B vs. C, D by Tukey HSD test for unequal sample sizes in post hoc comparisons. ND ¼ not detectable, which means less than limit of detection (LOD ¼ 0.03 mg/ml for U-NMF and 0.02 mg/ml for U-DMF); when calculating the GM and GSD, ND was designated as a half of LOD.
ANOVA tests. For U-NMF, the factory-to-factory differences were found between A vs. C and D, and B vs. C and D, by Tukey HSD test for unequal sample sizes. For U-DMF, they were between A vs. C and D. and B vs. C and D. Simple linear regression tests were applied to determine the relations of two urinary biomarkers (U-NMF and U-DMF) to airborne exposure (A-DMF) and dermal exposure (hands and forearms). We found that the regression coefficients for all exposure variables were significant for both urinary biomarkers. For U-NMF, they were 1.13, 0.51, and 0.54 for A-DMF, hands, and forearms, respectively, and for U-DMF, they were 1.02, 0.39, and 0.46 (models I-VI in Table 5 ). The positive regression coefficients suggested that both the increases of the exposure in air and on the skin resulted in increases of urinary biomarker levels. To adjust the individual contribution of various exposure variables to the biomarker levels, multiple linear regression tests were used. Only A-DMF and DMF on the hands remained significant (Po0.001) (models VII and VIII in Table 6 ). After removing the insignificant variable of DMF on forearms, we found that the regression coefficients of A-DMF and hands were 0.62, 0.36 for U-NMF and 0.69, 0.22 for U-DMF in the final multiple regression models (models IX and X). Based on the final models, per unit of the increment of naturally logarithmic hands' exposure, that is, log (mg/cm 2 ), could contribute to 0.36-and 0.22-fold increment of log (mg/l) of U-NMF and U-DMF, respectively. For A-DMF parts, they were 0.62-and 0.69-fold. After antilog conversion, the net contributions of per unit increment of hands' exposure (mg/cm 2 ) and A-DMF exposure (ppm) to U-NMF were 0.53 and 0.68 mg/l, respectively. To U-DMF, they were 0.46 and 0.73 mg/l for per unit increment of hands' exposure (mg/cm 2 ) and A-DMF exposure (ppm), respectively.
Discussion
Exposure via the dermal route has recently raised increasing concerns for a number of chemical hazards frequently used in occupational settings. DMF, due to its great solvent power Mraz and Nohova (1992) found an average absorption rate for DMF liquid of 9.4 mg/cm 2 h and an absorbed dose proportion via the skin (skin against skin þ inhalation) for DMF vapor exposure of 13-36% at 50 mg/m 3 (about 16.7 ppm). Nomiyama et al., however, found an absorbed dose ratio of 59.6% via the skin and 40.4% via inhalation for DMF vapor concentrations between 6.2 and 7.1 ppm. These estimates of DMF skin absorption parameters, however, might be different from those in the field because of the substantial discrepancy between exposure scenarios. For example, the human subjects in Nomiyama's study wore only cotton underpants and 90% of their skin surface was naked, a scenario considerably different from that typical of our factory workers, who had only uncovered hands, forearms, and faces in their actual occupational settings.
A number of previous investigators recognized the significance of dermal exposure to DMF in occupational settings. Yang and co-workers conducted a study on 345 workers directly exposed to DMF in 15 workshops in the synthetic fiber, fiber coating, synthetic leather, and paintmanufacturing industries (Yang et al., 2000) . Based on the workers' departments and job descriptions, they were categorized into three groups: continuous and direct exposure through inhalation and skin; intermittent and short-term exposure through inhalation and skin; and continuous and indirect exposure mostly through inhalation. They concluded that for the dermal and inhalation exposure groups, the U-NMF corresponding to 10 ppm was 39.1 mg/g creatinine, and 24.2 mg/g for the inhalation exposure-only group. Previous studies conducted in actual occupational environments have pointed out that the potentially significant contribution of the total body burden of DMF exposure via skin exposure might be substantial.
The lack of measurement of dermal exposure, however, might cause estimate imprecision in calculating the exposuredose relationship. Wrbitzky and Angerer examined the relationship between A-DMF and U-NMF from 126 synthetic fiber workers (Wrbitzky and Angerer, 1998) . They attributed their failure to find a significant association between them to dermal absorption or protective clothing. Again, in the present study, if dermal exposure had not been taken into consideration, 1.13 and 1.02 mg/l of increment of U-NMF and U-DMF would have accounted for the contribution by the per-unit increment of A-DMF (the slopes in Models III and VI in Table 4 ). However, only 0.62 and 0.69 mg/l of increment of U-NMF and U-DMF were attributed to per-unit increment of A-DMF if dermal exposure was considered (the slopes in Models IX and X in Table 5 ). The almost 80% ( ¼ (1.13À0.62)/0.62 * 100% for U-NMF) and almost 50% ( ¼ (1.02À0.69)/0.69 * 100% for U-DMF) of the offsets suggested the serious overestimation of A-DMF contribution to the total body burden. This study was, to the best of our knowledge, the first to quantitatively determine the contribution of skin DMF exposure to the body burden of DMF in an actual occupational environment.
The methods used for quantitative assessment of dermal exposure in the literature were UV fluorescence tracing, hand washing, patching, and taping (Schneider et al., 2000) . UV fluorescence tracing was not feasible for the present study because of its possible negative effects on the products being manufactured. Hand washing demands a great volume of solvents and is feasible only when examining hands exclusively. The patching method assesses only contaminants on the skin surface and cannot be used to determine the masking effect on the skin covered by clothing. The taping method was selected for the present study because of its ability to capture both the contaminant on the skin surface and a partial amount of contaminant deposited onto the stratum corneum of the epidermis (Rougier et al., 1999) . The basic assumption for the choice of method used in the present study was that the taped amount from the skin was total or proportional to the accumulative exposure on the skin at the time collected (immediately at the end of the each participant's workday) from the beginning of the exposure of the day. In view of the infrequent washing by participants of hands and forearms during work, and the trace loss from evaporation from the skin due to the relatively high boiling point of DMF (1501C), the assumption could be accepted to some degree. Moreover, previous studies have demonstrated that exposure from both skin liquid and skin vapor was considerable (Mraz and Nohova, 1992; Wrbitzky and Angerer, 1998; Yang et al., 2000; Nomiyama et al., 2001) . By using the taping method, both liquid and vapor forms of DMF were measured together. The present study was, however, not able to make a clear distinction between them.
The hands' exposure, but not forearms' exposure, was found significant in the association with both U-NMF and U-DMF in final models of multiple regression tests (Models XI and X in Table 6 ). This could result from the high colinearity between two variables (r ¼ 0.87, Po0.001, data not shown). On the other hand, based on the observation in the field investigation, during manufacturing processes of these DMF-related industries, hands are easier to get contact with DMF-containing solution than forehands. In this study, we found that the dermal exposure for the workers in synthetic leather industries was significantly-higher than in copper-laminated circuit board and in synthetic acrylic fiber industries (Table 3 ). There are three main steps in the wet manufacturing processes in the production of the synthetic leather: mixing, fabricating, and post-treatment. In the mixing step, the solvents composed of mainly DMF and lesser quantities of methylethyl ketone (MEK), acetone, toluene, etc., are mixed with pigment, polyurethane, or other resins in a tank, and then are pumped into a fabric in the fabrication step. Finally, the fabricating products are then dipped into water and are heated to dryness repeatedly in the post-treatment step. The hands of the workers are easily exposed to DMF-containing liquid in the mixing and fabricating steps. This also provided the basis why the hands had more dermal exposure to DMF than the forearms. The workers in the other two factories could be exposed to DMFcontaining liquids only during machine cleaning, which was only performed in the end of the workweek. Our study did not cover this operation for these two factory workers in the period of our study. The finding of greater dermal exposure to DMF for the workers in synthetic leather factories than in other two non-synthetic leather factories in our study was consistent to the field observation.
U-NMF, one of the metabolism-required biomarkers of DMF exposure, has long been extensively used as an exposure biomarker for DMF (ACGIH, 1999; Deutsche Forschungsgemeinschaft, 2000) . U-DMF, the non-metabolized biomarker has also been reported to show satisfactory relations with A-DMF exposure (Lareo and Perbellini, 1995; Chang et al., 2003) . The half-lives of U-NMF and U-DMF are about 5.1 h (Kafferlein et al., 2000) and 2 h (Mraz and Nohova, 1992) , respectively. This study has demonstrated that the dermal exposure, in addition to the respiratory exposure, contributed to both biomarkers of DMF exposure significantly (Model IX in Table 6 ). This suggested that the contribution of the dermal exposure to the total body burden of occupational exposure to DMF can be reflected well both in a rapidly biodegradable biomarker (U-DMF) and in a relatively long-lasting biomarker (U-NMF).
Taken together, based on our empirical measurements of A-DMF and dermal DMF exposure during work, and of the two urinary biomarkers of the total body burden of DMF, we concluded that skin exposure, in addition to the respiratory exposure, to DMF in occupational environments should be a noteworthy concern. Per-unit increments of hand exposure (mg/cm 2 ) and airborne exposure (ppm) could contribute to 0.53 and 0.68 mg/l of the increment of U-NMF and 0.46 and 0.73 mg/l of U-DMF, respectively, given the daily airborne exposure to DMF at about 1.51 ppm (geometric mean of time-weighted average airborne concentration determined from all 75 subjects in Table 2 ). The substantial contribution of dermal exposure to the total body burden of DMF was confirmed. A control remedy such as enforcing that DMF-exposed workers wear DMF-impermeable gloves should be implemented with the highest priority.
